Title | PTP1B-dependent regulation of receptor tyrosine kinase signaling by the actin-binding protein Mena. |
Publication Type | Journal Article |
Year of Publication | 2015 |
Authors | Hughes, SK, Oudin, MJ, Tadros, J, Neil, J, Del Rosario, A, Joughin, BA, Ritsma, L, Wyckoff, J, Vasile, E, Eddy, R, Philippar, U, Lussiez, A, Condeelis, JS, van Rheenen, J, White, F, Lauffenburger, DA, Gertler, FB |
Journal | Mol Biol Cell |
Volume | 26 |
Issue | 21 |
Pagination | 3867-78 |
Date Published | 2015 Nov 1 |
ISSN | 1939-4586 |
Abstract | During breast cancer progression, alternative mRNA splicing produces functionally distinct isoforms of Mena, an actin regulator with roles in cell migration and metastasis. Aggressive tumor cell subpopulations express Mena(INV), which promotes tumor cell invasion by potentiating EGF responses. However, the mechanism by which this occurs is unknown. Here we report that Mena associates constitutively with the tyrosine phosphatase PTP1B and mediates a novel negative feedback mechanism that attenuates receptor tyrosine kinase signaling. On EGF stimulation, complexes containing Mena and PTP1B are recruited to the EGFR, causing receptor dephosphorylation and leading to decreased motility responses. Mena also interacts with the 5' inositol phosphatase SHIP2, which is important for the recruitment of the Mena-PTP1B complex to the EGFR. When Mena(INV) is expressed, PTP1B recruitment to the EGFR is impaired, providing a mechanism for growth factor sensitization to EGF, as well as HGF and IGF, and increased resistance to EGFR and Met inhibitors in signaling and motility assays. In sum, we demonstrate that Mena plays an important role in regulating growth factor-induced signaling. Disruption of this attenuation by Mena(INV) sensitizes tumor cells to low-growth factor concentrations, thereby increasing the migration and invasion responses that contribute to aggressive, malignant cell phenotypes. |
DOI | 10.1091/mbc.E15-06-0442 |
Alternate Journal | Mol. Biol. Cell |
PubMed ID | 26337385 |
PubMed Central ID | PMC4626070 |
Grant List | CA100324 / CA / NCI NIH HHS / United States CA150344 / CA / NCI NIH HHS / United States GM58801 / GM / NIGMS NIH HHS / United States P01 CA100324 / CA / NCI NIH HHS / United States P30 CA013330 / CA / NCI NIH HHS / United States P30 CA014051 / CA / NCI NIH HHS / United States P30 CA016672 / CA / NCI NIH HHS / United States P30-CA14051 / CA / NCI NIH HHS / United States R01 CA150344 / CA / NCI NIH HHS / United States R01 GM058801 / GM / NIGMS NIH HHS / United States U54 CA112967 / CA / NCI NIH HHS / United States U54-CA112967 / CA / NCI NIH HHS / United States |